EndoGene.Bio

Active

Epigenetic diagnostics for early endometriosis detection.

What it does

EndoGene.Bio develops a non-invasive menstrual-blood test using epigenetic biomarkers to detect endometriosis. Patients collect samples at home and get diagnostic results within two clinic visits, cutting current seven-year delays and improving access to care.

Its site says now · captured 2026-08-23

endogene.bio | Unlocking human uterine biology

We generate high-resolution biological data from menstrual blood to advance disease understanding, patient stratification, and drug discovery in uterine health.